4.4 Article

Pleiotropic Role of HSF1 in Neoplastic Transformation

期刊

CURRENT CANCER DRUG TARGETS
卷 14, 期 2, 页码 144-155

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1568009614666140122155942

关键词

Cancer; drug resistance; genomic instability; HSF1 inhibitors; HSPs; metastasis; p53 signaling

类别

资金

  1. Polish Ministry of Science and Higher Education [N N401 031837, N N301 002439]
  2. European Community [UDA - POKL-04.01.01-00-014/10-00]

向作者/读者索取更多资源

HSF1 (Heat Shock transcription Factor 1) is the main transcription factor activated in response to proteotoxic stress. Once activated, it induces an expression of heat shock proteins (HSPs) which enables cells to survive in suboptimal conditions. HSF1 could be also activated by altered kinase signaling characteristic for cancer cells, which is a probable reason for its high activity found in a broad range of tumors. There is rapidly growing evidence that HSF1 supports tumor initiation and growth, as well as metastasis and angiogenesis. It also modulates the sensitivity of cancer cells to therapy. Functions of HSF1 in cancer are connected with HSPs' activity, which generally protects cells from apoptosis, but also are independent of its classical targets. HSF1-dependent regulation of non-HSPs genes plays a role in cell cycle progression, glucose metabolism, autophagy and drug efflux. HSF1 affects the key cell-survival and regulatory pathways, including p53, RAS/MAPK, cAMP/PKA, mTOR and insulin signaling. Although the exact mechanism of HSF1 action is still somewhat obscure, HSF1 is becoming an attractive target in anticancer therapies, whose inhibition could enhance the effects of other treatments.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据